The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
MRK · Healthcare · Wide moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | ISRG | RMD | IRMD | MRK |
|---|---|---|---|---|
| Moat Score (0–100) | 90 | 92 (highest) | 91 | 89 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 95 | 100 (highest) | 100 (highest) | 88 |
| Pricing power | 100 (highest) | 96 | 100 (highest) | 98 |
| Returns on capital | 77 | 90 | 93 (highest) | — |
| Balance-sheet safety | 100 (highest) | 100 (highest) | 100 (highest) | 74 |
| Capital discipline | 77 | 72 | 60 | 97 (highest) |
| Price vs. high estimate | 270% above high estimate | 68% above high estimate | 290% above high estimate | 24% above high estimate (largest discount to high estimate) |
| Market cap | $119.8B | $28.6B | $1.2B | $324.1B |
| Moat tier | Wide moat | Wide moat | Wide moat | Wide moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |